70 related articles for article (PubMed ID: 11699327)
21. Can people with nonsevere major depression benefit from antidepressant medication?
Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
[TBL] [Abstract][Full Text] [Related]
22. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
[TBL] [Abstract][Full Text] [Related]
24. Action monitoring in major depressive disorder with psychomotor retardation.
Schrijvers D; de Bruijn ER; Maas Y; De Grave C; Sabbe BG; Hulstijn W
Cortex; 2008 May; 44(5):569-79. PubMed ID: 18387589
[TBL] [Abstract][Full Text] [Related]
25. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
Zimmerman M; Walsh E; Chelminski I; Dalrymple K
J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
[TBL] [Abstract][Full Text] [Related]
26. Impact of lingual gyrus volume on antidepressant response and neurocognitive functions in Major Depressive Disorder: a voxel-based morphometry study.
Jung J; Kang J; Won E; Nam K; Lee MS; Tae WS; Ham BJ
J Affect Disord; 2014 Dec; 169():179-87. PubMed ID: 25200096
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort.
Black CN; Bot M; Scheffer PG; Penninx BW
Psychol Med; 2017 Apr; 47(5):936-948. PubMed ID: 27928978
[TBL] [Abstract][Full Text] [Related]
28. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
[TBL] [Abstract][Full Text] [Related]
29. Duloxetine plasma level and antidepressant response.
De Donatis D; Florio V; Porcelli S; Saria A; Mercolini L; Serretti A; Conca A
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():127-132. PubMed ID: 30611837
[TBL] [Abstract][Full Text] [Related]
30. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
[TBL] [Abstract][Full Text] [Related]
31. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
32. Suicide rates in short-term randomized controlled trials of newer antidepressants.
Hammad TA; Laughren TP; Racoosin JA
J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
[TBL] [Abstract][Full Text] [Related]
33. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
34. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
Suri R; Altshuler L; Hellemann G; Burt VK; Aquino A; Mintz J
Am J Psychiatry; 2007 Aug; 164(8):1206-13. PubMed ID: 17671283
[TBL] [Abstract][Full Text] [Related]
35. EEG connectivity between the subgenual anterior cingulate and prefrontal cortices in response to antidepressant medication.
Iseger TA; Korgaonkar MS; Kenemans JL; Grieve SM; Baeken C; Fitzgerald PB; Arns M
Eur Neuropsychopharmacol; 2017 Apr; 27(4):301-312. PubMed ID: 28237506
[TBL] [Abstract][Full Text] [Related]
36. Urinary neopterine levels in patients with major depressive disorder: alterations after treatment with paroxetine and comparison with healthy controls.
Taymur I; Özdel K; Özen NE; Güngör BB; Atmaca M
Psychiatr Danub; 2015 Mar; 27(1):25-30. PubMed ID: 25751446
[TBL] [Abstract][Full Text] [Related]
37. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder.
Lee SH; Lee KJ; Lee HJ; Ham BJ; Ryu SH; Lee MS
Psychiatry Clin Neurosci; 2005 Apr; 59(2):140-5. PubMed ID: 15823158
[TBL] [Abstract][Full Text] [Related]
38. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study.
Yao Z; Wang L; Lu Q; Liu H; Teng G
J Affect Disord; 2009 Jun; 115(3):430-8. PubMed ID: 19007997
[TBL] [Abstract][Full Text] [Related]
39. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
[TBL] [Abstract][Full Text] [Related]
40. Treatment response and cognitive impairment in major depression: association with C-reactive protein.
Chang HH; Lee IH; Gean PW; Lee SY; Chi MH; Yang YK; Lu RB; Chen PS
Brain Behav Immun; 2012 Jan; 26(1):90-5. PubMed ID: 21839826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
